We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
87 hedge funds and large institutions have $65.9M invested in Invesco Pharmaceuticals ETF in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% more capital invested
Capital invested by funds: $64M → $65.9M (+$1.92M)
0% more funds holding
Funds holding: 87 → 87 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0.77% less ownership
Funds ownership: 21.39% → 20.61% (-0.77%)
37% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 27
Holders
87
Holders Change
–
Holders Change %
0%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
27
Closed
9
Calls
$242K
Puts
–
Net Calls
+$242K
Net Calls Change
+$242K
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$2.38M |
| 2 |
PWW
Pettyjohn Wood & White
Lynchburg,
Virginia
|
+$1.53M |
| 3 |
HAS
HBW Advisory Services
Simi Valley,
California
|
+$1.09M |
| 4 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$1.06M |
| 5 |
EH
Equitable Holdings
New York
|
+$205K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$6.68M |
| 2 |
Goldman Sachs
New York
|
-$2.56M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$880K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$759K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$407K |
